当前位置:
X-MOL 学术
›
Nat. Rev. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Kidney cancer: PBRM1 loss promotes tumour response to immunotherapy
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2018-01-23 , DOI: 10.1038/nrclinonc.2018.12 Grant Otto
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2018-01-23 , DOI: 10.1038/nrclinonc.2018.12 Grant Otto
Kidney cancer: PBRM1 loss promotes tumour response to immunotherapy
中文翻译:
肾脏癌:PBRM1丢失促进肿瘤对免疫治疗的反应
肾脏癌:PBRM1丢失促进肿瘤对免疫治疗的反应
更新日期:2018-01-23
Kidney cancer: PBRM1 loss promotes tumour response to immunotherapy, Published online: 23 January 2018; doi:10.1038/nrclinonc.2018.12
Kidney cancer: PBRM1 loss promotes tumour response to immunotherapy中文翻译:
肾脏癌:PBRM1丢失促进肿瘤对免疫治疗的反应
肾脏癌:PBRM1丢失促进肿瘤对免疫治疗的反应
肾癌:PBRM1丢失促进肿瘤对免疫疗法的反应,在线发布:2018年1月23日; doi:10.1038 / nrclinonc.2018.12
肾脏癌:PBRM1丢失促进肿瘤对免疫治疗的反应